Drugs / Flupentixol

Trials 11 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00000349 cocaine dependence National Institute on Drug Abuse (NIDA) Unknown No outcome recorded
Phase 23 trials
Phase 2 NCT00000274 Mar 1997 → May 1999 cocaine dependence National Institute on Drug Abuse (NIDA) Completed No outcome recorded
Phase 2 NCT00000266 Aug 1994 → Dec 2001 cocaine dependence National Institute on Drug Abuse (NIDA) Completed No outcome recorded
Phase 2 NCT00000241 Feb 1994 → May 1996 substance-related disorder National Institute on Drug Abuse (NIDA) Completed No outcome recorded
Phase 33 trials
Phase 3 NCT03205228 Jul 2017 → Jun 2018 Mahidol University Completed No outcome recorded
Phase 3 NCT02374567 Jan 2015 → Jun 2017 anxiety disorder, dementia, depressive disorder, schizophrenia +1 Hannover Medical School Terminated No outcome recorded
Phase 3 NCT01765829 Nov 2012 → Nov 2015 psychotic disorder Fundación Pública Andaluza Progreso y Salud Unknown No outcome recorded
Phase 43 trials
Phase 4 NCT06927375 Dec 2024 → Nov 2025 overdue disease of orbital part of eye adnexa Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Recruiting No outcome recorded
Phase 4 NCT04898270 Dec 2019 → Dec 2020 metabolic syndrome X, schizophrenia Taichung Veterans General Hospital Completed No outcome recorded
Phase 4 NCT04970667 Jan 2018 → Jan 2020 mood disorder Peking University Third Hospital Completed No outcome recorded
Phase not applicable1 trial
NCT05099913 Aug 2020 → Oct 2022 drug-induced mental disorder, dyspepsia, substance withdrawal syndrome RenJi Hospital Unknown No outcome recorded
Also used as a comparator or background therapy in 5 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT01323205 Background May 2011 → Nov 2012 schizophrenia Janssen Research & Development, LLC Completed No outcome recorded
Phase 2 NCT00000275 Background Nov 1996 → Mar 1998 substance-related disorder National Institute on Drug Abuse (NIDA) Completed No outcome recorded
Phase 42 trials
Phase 4 NCT01851863 Comparator May 2013 → Jun 2014 depressive disorder, dyspepsia RenJi Hospital Completed No outcome recorded
Phase 4 NCT01164059 Comparator Feb 2010 → Aug 2013 schizophrenia University of Bremen Completed No outcome recorded
Phase not applicable1 trial
NCT06756139 Comparator Nov 2024 → Nov 2025 overdue dyspepsia Air Force Military Medical University, China Recruiting No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 18 sources stand behind the page.

FieldValueCited text
Known as Flupentixol “Regular antipsychotic medications (Risperidone, Olanzapine, Clozapine, Amisulpride, Quetiapine, Paliperidone, Aripiprazole, Haloperidol, Levomepromazine, Zuclopenthixol...” NCT01323205
10

“Drugs: Aripiprazole, Olanzapine, Zuclopenthixol, Clotiapine, Flupentixol, Risperidone, Sulpiride, Trifluoperazine, Haloperidol, Quetiapine, Paliperidone, Chlorpromazine,...” NCT01765829

Flupentixol and Melitracen” NCT05099913

NCT03205228

NCT02374567

NCT06927375

NCT04970667

NCT01164059

NCT01851863

NCT06756139

NCT04898270

Known as Flupenthixol ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000349
4

NCT00000275

NCT00000241

NCT00000266

NCT00000274

Known as Flupentixol dihydrochloride “The active components of Deanxit are Flupentixol dihydrochloride (Flupentixol) and melitracen (melitracen).” NCT04970667
Known as LC 44 ChEMBL registry synonym — accepted as the source's own label CHEMBL6066864
Known as N-7009 ChEMBL registry synonym — accepted as the source's own label CHEMBL6066864
Route Oral “haloperidol [3-6 mg] or flupentixol [6-12 mg]) given orally” PMID 27265548 Jun 2016